BUPRENORPHINE

BUPRENORPHINE was reported 92989 times

These side effects are most commonly reported by patients taking BUPRENORPHINE:

# Side effect Count
0 DEATH 13431
1 DRUG DEPENDENCE 12544
2 OVERDOSE 11012
3 TOXICITY TO VARIOUS AGENTS 10813
4 PAIN 8340
5 DRUG WITHDRAWAL SYNDROME 7064
6 DRUG INEFFECTIVE 6458
7 EMOTIONAL DISTRESS 5454
8 NAUSEA 4596
9 DRUG ABUSE 3839
10 PRODUCT ADHESION ISSUE 3451
11 APPLICATION SITE RASH 3071
12 INADEQUATE ANALGESIA 3053
13 DIZZINESS 2787
14 RASH 2616
15 VOMITING 2481
16 HEADACHE 2414
17 APPLICATION SITE PRURITUS 2388
18 OFF LABEL USE 2273
19 FATIGUE 2054
20 DEPRESSION 1851
21 MATERNAL EXPOSURE DURING PREGNANCY 1846
22 DYSPNOEA 1808
23 DRUG WITHDRAWAL SYNDROME NEONATAL 1790
24 ANXIETY 1788
25 APPLICATION SITE ERYTHEMA 1777
26 SOMNOLENCE 1727
27 APPLICATION SITE IRRITATION 1713
28 DRUG EFFECT DECREASED 1689
29 CONFUSIONAL STATE 1651
30 DIARRHOEA 1605
31 MALAISE 1536
32 ASTHENIA 1519
33 INSOMNIA 1472
34 ARTHRALGIA 1459
35 FOETAL EXPOSURE DURING PREGNANCY 1336
36 ABDOMINAL PAIN UPPER 1330
37 FALL 1304
38 DRUG INTOLERANCE 1273
39 HYPERHIDROSIS 1272
40 CONDITION AGGRAVATED 1230
41 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1226
42 PRURITUS 1213
43 HYPOAESTHESIA 1160
44 GENERAL PHYSICAL HEALTH DETERIORATION 1134
45 PARAESTHESIA 1057
46 INTENTIONAL PRODUCT USE ISSUE 1056
47 FEELING ABNORMAL 1049
48 ABDOMINAL DISCOMFORT 1032
49 APPLICATION SITE VESICLES 1026
50 INJECTION SITE PAIN 1024
51 HYPERTENSION 1022
52 DRUG HYPERSENSITIVITY 1013
53 PNEUMONIA 1002
54 MEMORY IMPAIRMENT 993
55 WITHDRAWAL SYNDROME 974
56 CONSTIPATION 973
57 GASTROOESOPHAGEAL REFLUX DISEASE 973
58 DRUG INTERACTION 964
59 INTENTIONAL PRODUCT MISUSE 954
60 EPILEPSY 947
61 BLISTER 946
62 APPLICATION SITE PAIN 944
63 MUSCLE SPASMS 937
64 MIGRAINE 934
65 DRY MOUTH 927
66 PRODUCT USE IN UNAPPROVED INDICATION 921
67 ACCIDENTAL OVERDOSE 913
68 RHEUMATOID ARTHRITIS 897
69 URTICARIA 891
70 PRODUCT QUALITY ISSUE 890
71 PAIN IN EXTREMITY 886
72 APPLICATION SITE REACTION 884
73 ALOPECIA 876
74 PERIPHERAL SWELLING 871
75 DECREASED APPETITE 865
76 WEIGHT INCREASED 862
77 EXPOSURE DURING PREGNANCY 858
78 SYSTEMIC LUPUS ERYTHEMATOSUS 857
79 PSORIATIC ARTHROPATHY 856
80 SWELLING 846
81 ARTHROPATHY 845
82 BLEPHAROSPASM 844
83 INJURY 842
84 PEMPHIGUS 825
85 TYPE 2 DIABETES MELLITUS 819
86 INFUSION RELATED REACTION 810
87 JOINT SWELLING 809
88 INFLAMMATION 793
89 PERICARDITIS 792
90 SYNOVITIS 792
91 WOUND 791
92 BURSITIS 788
93 GLOSSODYNIA 788
94 NASOPHARYNGITIS 786
95 DUODENAL ULCER PERFORATION 785
96 PRODUCT USE ISSUE 785
97 BREAST CANCER STAGE III 782
98 FIBROMYALGIA 782
99 C-REACTIVE PROTEIN INCREASED 770
100 HAND DEFORMITY 768
101 SLEEP DISORDER 763
102 HEPATIC ENZYME INCREASED 759
103 TASTE DISORDER 755
104 ABDOMINAL PAIN 748
105 FOLLICULITIS 748
106 STOMATITIS 748
107 WHEEZING 744
108 HELICOBACTER INFECTION 743
109 MUSCULAR WEAKNESS 742
110 FACET JOINT SYNDROME 733
111 LOWER RESPIRATORY TRACT INFECTION 731
112 BLOOD CHOLESTEROL INCREASED 721
113 CONTRAINDICATED PRODUCT ADMINISTERED 717
114 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 700
115 APPLICATION SITE BURN 699
116 LIVER INJURY 690
117 OSTEOARTHRITIS 689
118 MOBILITY DECREASED 688
119 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 685
120 HYPERSENSITIVITY 684
121 THERAPEUTIC PRODUCT EFFECT DECREASED 682
122 IMPAIRED HEALING 671
123 WOUND INFECTION 665
124 LUNG DISORDER 653
125 PYREXIA 653
126 MUSCLE INJURY 646
127 NECK PAIN 646
128 IRRITABLE BOWEL SYNDROME 643
129 GAIT INABILITY 637
130 DYSPEPSIA 633
131 HYPERCHOLESTEROLAEMIA 632
132 LIP DRY 628
133 NIGHT SWEATS 621
134 BACK INJURY 618
135 OBESITY 612
136 NAIL DISORDER 610
137 JOINT RANGE OF MOTION DECREASED 602
138 GASTROINTESTINAL DISORDER 601
139 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 601
140 MUSCULOSKELETAL PAIN 595
141 PERIPHERAL VENOUS DISEASE 590
142 SKIN IRRITATION 584
143 TREATMENT FAILURE 583
144 WEIGHT DECREASED 577
145 NO ADVERSE EVENT 573
146 UNEVALUABLE EVENT 572
147 ONYCHOMADESIS 567
148 MUSCULOSKELETAL STIFFNESS 564
149 LIVE BIRTH 559
150 ABDOMINAL DISTENSION 553
151 RHEUMATIC FEVER 552
152 MENTAL DISORDER 550
153 INJECTION SITE REACTION 543
154 TACHYCARDIA 540
155 DRUG-INDUCED LIVER INJURY 519
156 HALLUCINATION 519
157 BACK PAIN 511
158 COMA 510
159 SUICIDAL IDEATION 508
160 SUBSTANCE ABUSE 502
161 ILL-DEFINED DISORDER 501
162 OEDEMA PERIPHERAL 496
163 CHEST PAIN 495
164 TREMOR 494
165 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 487
166 LIVER FUNCTION TEST INCREASED 487
167 EXTRA DOSE ADMINISTERED 483
168 GRIP STRENGTH DECREASED 483
169 LOSS OF CONSCIOUSNESS 481
170 CHILLS 469
171 LEARNING DISABILITY 468
172 WRONG TECHNIQUE IN DRUG USAGE PROCESS 461
173 DRUG EFFECT INCREASED 453
174 MYALGIA 444
175 BLOOD PRESSURE INCREASED 430
176 GAIT DISTURBANCE 425
177 HYPOTENSION 424
178 AMNESIA 422
179 DRUG USE DISORDER 422
180 COUGH 421
181 HEPATITIS 421
182 ONYCHOMYCOSIS 421
183 ORAL ADMINISTRATION COMPLICATION 420
184 COELIAC DISEASE 416
185 C-REACTIVE PROTEIN ABNORMAL 410
186 SYNCOPE 410
187 THERAPEUTIC RESPONSE DECREASED 409
188 HOSPITALISATION 406
189 DRUG ADMINISTERED AT INAPPROPRIATE SITE 404
190 SEDATION 403
191 APPLICATION SITE DISCOLOURATION 402
192 DISABILITY 402
193 AGITATION 392
194 DEVELOPMENTAL DELAY 386
195 PRODUCT SOLUBILITY ABNORMAL 383
196 INJECTION SITE ERYTHEMA 382
197 SEIZURE 377
198 SEPSIS 368
199 ROAD TRAFFIC ACCIDENT 365
200 CONGENITAL ANOMALY 364
201 CARDIO-RESPIRATORY ARREST 362
202 EUPHORIC MOOD 361
203 FINGER DEFORMITY 360
204 RESPIRATORY DEPRESSION 358
205 DISCOMFORT 357
206 CARDIAC DISORDER 356
207 DRUG DIVERSION 345
208 PALPITATIONS 344
209 VISION BLURRED 340
210 ADVERSE REACTION 339
211 ACUTE KIDNEY INJURY 335
212 PRODUCT LABEL CONFUSION 335
213 CONTUSION 324
214 INFECTION 316
215 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 311
216 AGGRESSION 308
217 TINNITUS 308
218 ILLNESS 307
219 SUBSTANCE USE DISORDER 303
220 DELIRIUM 302
221 ERYTHEMA 302
222 ALTERED STATE OF CONSCIOUSNESS 301
223 MIOSIS 295
224 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 294
225 PRODUCT DOSE OMISSION ISSUE 294
226 SUICIDE ATTEMPT 294
227 SKIN REACTION 293
228 HAEMATEMESIS 291
229 BREAKTHROUGH PAIN 290
230 LETHARGY 286
231 ADVERSE DRUG REACTION 285
232 ADVERSE EVENT 284
233 BLINDNESS 281
234 ASTHMA 279
235 DISTURBANCE IN ATTENTION 272
236 DEPENDENCE 271
237 THERAPEUTIC RESPONSE SHORTENED 264
238 COMPLETED SUICIDE 262
239 DYSARTHRIA 255
240 DRUG SCREEN POSITIVE 251
241 UNDERDOSE 248
242 HEPATITIS C 245
243 PULMONARY OEDEMA 244
244 URINARY TRACT INFECTION 244
245 DIPLOPIA 241
246 DISORIENTATION 241
247 PRESYNCOPE 239
248 OEDEMA 237
249 RHABDOMYOLYSIS 236
250 DRUG SCREEN NEGATIVE 235
251 INFUSION SITE REACTION 235
252 PRODUCT PHYSICAL ISSUE 234
253 COGNITIVE DISORDER 230
254 DEPRESSED LEVEL OF CONSCIOUSNESS 230
255 HAEMATURIA 230
256 EYE PAIN 228
257 PRODUCT SUBSTITUTION ISSUE 225
258 HEAD DISCOMFORT 223
259 HAEMORRHAGIC STROKE 221
260 TOOTH LOSS 221
261 GENERALISED OEDEMA 219
262 RESTLESSNESS 215
263 CARDIAC ARREST 213
264 ASCITES 212
265 DENTAL CARIES 211
266 DRUG TOLERANCE 210
267 PHOTOPHOBIA 208
268 APPLICATION SITE URTICARIA 205
269 BALANCE DISORDER 202
270 HEART RATE INCREASED 202
271 MENTAL IMPAIRMENT 202
272 APPLICATION SITE SCAR 200
273 OCULAR DISCOMFORT 198
274 INCORRECT DOSE ADMINISTERED 197
275 IRRITABILITY 197
276 APPLICATION SITE EXFOLIATION 195
277 PRESCRIBED OVERDOSE 195
278 URINARY TRACT DISORDER 195
279 AMAUROSIS FUGAX 193
280 DYSPHAGIA 193
281 PRODUCT PHYSICAL CONSISTENCY ISSUE 192
282 ABNORMAL BEHAVIOUR 189
283 APPLICATION SITE DISCHARGE 188
284 INTENTIONAL OVERDOSE 188
285 SINUSITIS 187
286 BURNING SENSATION 186
287 DERMATITIS CONTACT 186
288 PRODUCT PACKAGING QUANTITY ISSUE 186
289 ANAEMIA 185
290 APPLICATION SITE EROSION 184
291 FEELING HOT 184
292 DEHYDRATION 182
293 INJECTION SITE SWELLING 182
294 VISUAL IMPAIRMENT 182
295 DEVICE LEAKAGE 176
296 HOT FLUSH 176
297 PREMATURE BABY 176
298 URINARY RETENTION 174
299 UNRESPONSIVE TO STIMULI 173
300 ASPHYXIA 171
301 AUTOIMMUNE DISORDER 171
302 NEUROPATHY PERIPHERAL 171
303 INFLUENZA LIKE ILLNESS 168
304 INJECTION SITE INFECTION 168
305 INJECTION SITE PRURITUS 168
306 MEDICATION ERROR 167
307 CHEST DISCOMFORT 166
308 POST-TRAUMATIC STRESS DISORDER 163
309 CEREBROVASCULAR ACCIDENT 162
310 SEROTONIN SYNDROME 160
311 BRAIN OEDEMA 159
312 APPLICATION SITE SWELLING 158
313 LIVER DISORDER 157
314 LOWER LIMB FRACTURE 157
315 RESPIRATORY ARREST 157
316 HYPERAESTHESIA 156
317 INJECTION SITE EXTRAVASATION 156
318 IMPAIRED WORK ABILITY 154
319 RENAL FAILURE 153
320 IMPAIRED DRIVING ABILITY 151
321 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 149
322 MYOCARDIAL INFARCTION 145
323 OXYGEN SATURATION DECREASED 145
324 ANGER 143
325 VERTIGO 143
326 ARTHRITIS 142
327 NORMAL NEWBORN 142
328 RESPIRATORY DISORDER 142
329 SCIATICA 142
330 PNEUMONIA ASPIRATION 141
331 SWELLING FACE 140
332 INJECTION SITE BRUISING 139
333 PARANOIA 138
334 DRUG DETOXIFICATION 137
335 POISONING 136
336 DEPRESSED MOOD 135
337 SWOLLEN JOINT COUNT INCREASED 134
338 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 133
339 THERAPY NON-RESPONDER 133
340 EAR PAIN 132
341 PSYCHOTIC DISORDER 132
342 PRURITUS GENERALISED 129
343 APPLICATION SITE DRYNESS 128
344 RESTLESS LEGS SYNDROME 128
345 SURGERY 128
346 BREAST CANCER STAGE II 127
347 HEPATIC CIRRHOSIS 127
348 NERVOUSNESS 126
349 PREMATURE DELIVERY 126
350 STRESS 126
351 INCORRECT PRODUCT ADMINISTRATION DURATION 125
352 LARYNGITIS 125
353 PANIC ATTACK 125
354 ATRIAL FIBRILLATION 123
355 RHEUMATOID FACTOR POSITIVE 123
356 TOOTHACHE 123
357 OSTEOPOROSIS 121
358 BONE EROSION 120
359 PSORIASIS 120
360 DERMATITIS ALLERGIC 119
361 DYSURIA 119
362 EXOSTOSIS 119
363 PULMONARY EMBOLISM 119
364 JOINT STIFFNESS 118
365 RHINORRHOEA 118
366 COVID-19 117
367 NIGHTMARE 117
368 PULMONARY FIBROSIS 117
369 RENAL IMPAIRMENT 117
370 HYPERSOMNIA 116
371 DEEP VEIN THROMBOSIS POSTOPERATIVE 115
372 OROPHARYNGEAL PAIN 115
373 PRESCRIBED UNDERDOSE 115
374 RED BLOOD CELL SEDIMENTATION RATE INCREASED 115
375 RESPIRATORY FAILURE 114
376 EXPOSURE VIA BREAST MILK 113
377 PRODUCT ADMINISTRATION ERROR 113
378 PRODUCT PRESCRIBING ERROR 113
379 DISLOCATION OF VERTEBRA 112
380 BRADYCARDIA 111
381 ORAL DISCOMFORT 111
382 TREATMENT NONCOMPLIANCE 111
383 CROHN^S DISEASE 110
384 INFLUENZA 110
385 INJECTION SITE INDURATION 110
386 CELLULITIS 109
387 QUALITY OF LIFE DECREASED 108
388 ELECTROCARDIOGRAM QT PROLONGED 107
389 RESPIRATORY DISTRESS 107
390 CARDIAC FAILURE 106
391 DRUG DELIVERY SYSTEM REMOVAL 106
392 LIP SWELLING 106
393 MOOD SWINGS 106
394 PRODUCT PRESCRIBING ISSUE 106
395 SKIN BURNING SENSATION 106
396 HYPONATRAEMIA 105
397 INJECTION SITE MASS 105
398 INJECTION SITE NECROSIS 103
399 TOOTH DISORDER 102
400 BRONCHITIS 101
401 HYPOGLYCAEMIA 101
402 HYPOKALAEMIA 100
403 CHRONIC KIDNEY DISEASE 99
404 HYPOXIA 99
405 IMPAIRED QUALITY OF LIFE 99
406 INJECTION SITE ABSCESS 99
407 RASH GENERALISED 99
408 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 99
409 X-RAY ABNORMAL 99
410 COLD SWEAT 98
411 HALLUCINATION, VISUAL 98
412 TOOTH FRACTURE 98
413 APPLICATION SITE SCAB 97
414 DEMENTIA 97
415 ULCER HAEMORRHAGE 97
416 THROMBOCYTOPENIA 96
417 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 94
418 CRYING 94
419 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 94
420 THERMAL BURN 93
421 FLUSHING 92
422 POISONING DELIBERATE 92
423 ALCOHOL ABUSE 91
424 DYSGEUSIA 91
425 PANCREATITIS 91
426 BRAIN INJURY 90
427 ABORTION SPONTANEOUS 89
428 BONE PAIN 89
429 DRUG LEVEL FLUCTUATING 89
430 INJECTION SITE CELLULITIS 89
431 INJECTION SITE ULCER 89
432 MYELOPATHY 88
433 TOOTH EROSION 88
434 URINARY INCONTINENCE 88
435 APPLICATION SITE HAEMORRHAGE 87
436 DYSKINESIA 87
437 RASH PRURITIC 87
438 CARDIAC FAILURE CONGESTIVE 86
439 DRUG EFFECT INCOMPLETE 86
440 GENERAL PHYSICAL CONDITION ABNORMAL 86
441 ACCIDENTAL EXPOSURE TO PRODUCT 85
442 ARRHYTHMIA 85
443 BLOOD PRESSURE DECREASED 85
444 DYSPHONIA 85
445 ERECTILE DYSFUNCTION 85
446 GASTROINTESTINAL HAEMORRHAGE 85
447 NEURALGIA 85
448 PRODUCT CONTAMINATION 85
449 UPPER RESPIRATORY TRACT INFECTION 85
450 ACCIDENTAL POISONING 84
451 LUPUS-LIKE SYNDROME 84
452 SWOLLEN TONGUE 84
453 APPLICATION SITE HYPERSENSITIVITY 83
454 FEELING JITTERY 83
455 FLUID RETENTION 83
456 RECTAL HAEMORRHAGE 83
457 SLEEP APNOEA SYNDROME 83
458 ENCEPHALOPATHY 82
459 SPEECH DISORDER 82
460 SPINA BIFIDA 82
461 THINKING ABNORMAL 80
462 DELUSION 79
463 MYDRIASIS 78
464 NEUTROPENIA 78
465 BEDRIDDEN 77
466 DRUG EFFECT LESS THAN EXPECTED 77
467 PULMONARY CONGESTION 77
468 BRADYPNOEA 76
469 HIP ARTHROPLASTY 76
470 LUPUS VULGARIS 76
471 THERAPEUTIC RESPONSE UNEXPECTED 76
472 ASPIRATION 75
473 MUSCLE TWITCHING 75
474 PRODUCT TASTE ABNORMAL 75
475 HEPATIC ENZYME 74
476 SKIN EXFOLIATION 74
477 DEEP VEIN THROMBOSIS 73
478 FEELING COLD 73
479 FREQUENT BOWEL MOVEMENTS 73
480 MENTAL STATUS CHANGES 73
481 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 72
482 THERAPY CESSATION 72
483 LACRIMATION INCREASED 71
484 LEUKOPENIA 71
485 LOW BIRTH WEIGHT BABY 71
486 NERVOUS SYSTEM DISORDER 71
487 OVERLAP SYNDROME 71
488 APPLICATION SITE DERMATITIS 70
489 HAEMORRHAGE 70
490 PRODUCT DISPENSING ERROR 70
491 EMOTIONAL DISORDER 69
492 HALLUCINATION, AUDITORY 69
493 INJECTION SITE IRRITATION 69
494 INJECTION SITE WARMTH 69
495 KNEE ARTHROPLASTY 69
496 YAWNING 69
497 EPISTAXIS 68
498 MOOD ALTERED 68
499 WHITE BLOOD CELL COUNT INCREASED 68
500 DYSSTASIA 67
501 HEAD INJURY 67
502 INTENTIONAL SELF-INJURY 66
503 METABOLIC ACIDOSIS 66
504 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 66
505 THROMBOSIS 66
506 BIPOLAR DISORDER 65
507 POLLAKIURIA 65
508 POOR FEEDING INFANT 65
509 DRY SKIN 64
510 EAR INFECTION 64
511 INTESTINAL OBSTRUCTION 64
512 PRODUCT COLOUR ISSUE 64
513 BLOOD CREATINE PHOSPHOKINASE INCREASED 63
514 MALIGNANT NEOPLASM PROGRESSION 63
515 PREGNANCY 63
516 STAPHYLOCOCCAL INFECTION 63
517 INJECTION SITE RASH 62
518 MOVEMENT DISORDER 62
519 POOR QUALITY SLEEP 62
520 CYANOSIS 61
521 FEELING OF BODY TEMPERATURE CHANGE 61
522 INJECTION SITE DISCHARGE 61
523 PRODUCT STORAGE ERROR 61
524 RENAL DISORDER 61
525 SMALL FOR DATES BABY 61
526 AFFECTIVE DISORDER 60
527 BEHAVIOUR DISORDER 60
528 DRUG LEVEL INCREASED 60
529 INJECTION SITE EROSION 60
530 NEPHROLITHIASIS 60
531 PLEURAL EFFUSION 60
532 SKIN DISORDER 60
533 HAEMOGLOBIN DECREASED 59
534 HEART RATE DECREASED 59
535 MUSCLE RIGIDITY 59
536 MYOCLONUS 59
537 SCAR 59
538 SEPTIC SHOCK 59
539 ANAPHYLACTIC REACTION 58
540 APATHY 58
541 CONVULSION 58
542 DRY EYE 58
543 LIBIDO DECREASED 58
544 LIMB INJURY 58
545 QUADRIPARESIS 58
546 BLOOD GLUCOSE INCREASED 57
547 CHROMATURIA 57
548 INJECTION SITE HAEMORRHAGE 57
549 RIB FRACTURE 57
550 SELF ESTEEM DECREASED 57
551 SKIN LESION 57
552 SPINAL OPERATION 57
553 WALKING AID USER 57
554 APHASIA 56
555 BACK DISORDER 56
556 C-REACTIVE PROTEIN 56
557 FEAR 56
558 INTENTIONAL DRUG MISUSE 56
559 PERSONALITY CHANGE 56
560 SENSORY DISTURBANCE 56
561 BLOOD PRESSURE FLUCTUATION 55
562 LOCAL SWELLING 55
563 LOGORRHOEA 55
564 MAJOR DEPRESSION 55
565 NEOPLASM MALIGNANT 55
566 PRODUCT DOSE OMISSION 55
567 APPLICATION SITE INFLAMMATION 54
568 COMPARTMENT SYNDROME 54
569 DISEASE PROGRESSION 54
570 GASTRIC ULCER 54
571 INCOHERENT 54
572 LIVER FUNCTION TEST ABNORMAL 54
573 MEDICATION RESIDUE PRESENT 54
574 MULTIPLE ORGAN DYSFUNCTION SYNDROME 54
575 ORTHOSTATIC HYPOTENSION 54
576 PRODUCT USE COMPLAINT 54
577 RASH ERYTHEMATOUS 54
578 SCHIZOPHRENIA 54
579 THERAPY INTERRUPTED 54
580 BODY TEMPERATURE DECREASED 53
581 COLITIS ULCERATIVE 53
582 HAEMATOCHEZIA 53
583 HEART RATE IRREGULAR 53
584 INTENTIONAL DOSE OMISSION 53
585 RASH VESICULAR 53
586 UPPER GASTROINTESTINAL HAEMORRHAGE 53
587 ACCIDENT 52
588 CARDIOMEGALY 52
589 DIABETES MELLITUS 52
590 FEELING DRUNK 52
591 HYPOTHYROIDISM 52
592 PORPHYRIA ACUTE 52
593 ABNORMAL DREAMS 51
594 ENDOCARDITIS 51
595 OCULAR HYPERAEMIA 51
596 RESPIRATORY TRACT INFECTION 51
597 DEVICE MALFUNCTION 50
598 FLATULENCE 50
599 FOOT FRACTURE 50
600 HYPOCHOLESTEROLAEMIA 50
601 INJECTION SITE INFLAMMATION 50
602 MATERNAL EXPOSURE TIMING UNSPECIFIED 50
603 SOMNAMBULISM 50
604 FOETAL GROWTH RESTRICTION 49
605 LIMB DISCOMFORT 49
606 NASAL CONGESTION 49
607 PALLOR 49
608 APPLICATION SITE BRUISE 48
609 IMPAIRED GASTRIC EMPTYING 48
610 INTENTIONAL UNDERDOSE 48
611 NERVE INJURY 48
612 PROCEDURAL PAIN 48
613 PRODUCT AVAILABILITY ISSUE 48
614 SKIN DISCOLOURATION 48
615 STRESS CARDIOMYOPATHY 48
616 SUBSTANCE USE 48
617 ACUTE RESPIRATORY DISTRESS SYNDROME 47
618 APPLICATION SITE ULCER 47
619 BLOOD CREATININE INCREASED 47
620 BRAIN FOG 47
621 LABORATORY TEST ABNORMAL 47
622 LOCALISED INFECTION 47
623 PRODUCT PACKAGING ISSUE 47
624 SNEEZING 47
625 THROAT TIGHTNESS 47
626 DRUG PRESCRIBING ERROR 46
627 JOINT DISLOCATION 46
628 PANCYTOPENIA 46
629 PLACENTAL DISORDER 46
630 RETINITIS 46
631 SKIN ULCER 46
632 APPLICATION SITE PERSPIRATION 45
633 INTERVERTEBRAL DISC PROTRUSION 45
634 JOINT INJURY 45
635 RENAL FAILURE ACUTE 45
636 SEXUAL DYSFUNCTION 45
637 APPLICATION SITE PAPULES 44
638 COORDINATION ABNORMAL 44
639 NEUROLEPTIC MALIGNANT SYNDROME 44
640 PRODUCT DISPENSING ISSUE 44
641 PRODUCT SIZE ISSUE 44
642 SPINAL PAIN 44
643 TONGUE DISCOMFORT 44
644 ECZEMA 43
645 MOUTH ULCERATION 43
646 PRODUCT ADMINISTRATION INTERRUPTED 43
647 SOPOR 43
648 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 43
649 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 42
650 ANGIOEDEMA 42
651 APPLICATION SITE DISCOMFORT 42
652 GENERALISED TONIC-CLONIC SEIZURE 42
653 HYPOPNOEA 42
654 INJECTION SITE VESICLES 42
655 TOOTH INJURY 42
656 ANGINA PECTORIS 41
657 BRADYKINESIA 41
658 DRUG DOSE OMISSION 41
659 HEPATIC FUNCTION ABNORMAL 41
660 JAUNDICE NEONATAL 41
661 PLATELET COUNT DECREASED 41
662 SPINAL FRACTURE 41
663 WHITE BLOOD CELL COUNT DECREASED 41
664 ALANINE AMINOTRANSFERASE INCREASED 40
665 APPLICATION SITE WARMTH 40
666 DYSPHORIA 40
667 DYSTONIA 40
668 EATING DISORDER 40
669 EXTRAPYRAMIDAL DISORDER 40
670 FEEDING DISORDER 40
671 INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION 40
672 MANIA 40
673 ORAL MUCOSAL BLISTERING 40
674 PRODUCT DOSE OMISSION IN ERROR 40
675 PSYCHOMOTOR HYPERACTIVITY 40
676 ATTENTION DEFICIT HYPERACTIVITY DISORDER 39
677 DEVICE ADHESION ISSUE 39
678 EXPOSURE DURING BREAST FEEDING 39
679 HEPATIC FAILURE 39
680 HYPERKALAEMIA 39
681 HYPOTHERMIA 39
682 MYOSITIS 39
683 PRODUCT ODOUR ABNORMAL 39
684 PRODUCTIVE COUGH 39
685 PUSTULAR PSORIASIS 39
686 APNOEA 38
687 APPLICATION SITE ODOUR 38
688 CHOLELITHIASIS 38
689 HIP FRACTURE 38
690 MALNUTRITION 38
691 OSTEOMYELITIS 38
692 PNEUMONITIS 38
693 PRE-EXISTING CONDITION IMPROVED 38
694 PRODUCT FORMULATION ISSUE 38
695 SUDDEN DEATH 38
696 THERAPEUTIC RESPONSE DELAYED 38
697 BLOOD PRESSURE SYSTOLIC INCREASED 37
698 CEREBRAL HAEMORRHAGE 37
699 CIRCULATORY COLLAPSE 37
700 DRUG ADMINISTRATION ERROR 37
701 DYSPNOEA EXERTIONAL 37
702 GASTRIC DISORDER 37
703 GOUT 37
704 HERPES ZOSTER 37
705 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 37
706 IMMUNE SYSTEM DISORDER 37
707 MULTIPLE CONGENITAL ABNORMALITIES 37
708 PERSECUTORY DELUSION 37
709 PHARYNGITIS STREPTOCOCCAL 37
710 TORSADE DE POINTES 37
711 ACUTE RESPIRATORY FAILURE 36
712 ALCOHOL INTERACTION 36
713 DEVICE ISSUE 36
714 DRUG LEVEL DECREASED 36
715 FEMUR FRACTURE 36
716 HYPOKINESIA 36
717 INTERVERTEBRAL DISC DEGENERATION 36
718 MULTIPLE SCLEROSIS 36
719 MUSCLE SPASTICITY 36
720 RETCHING 36
721 ACUTE MYOCARDIAL INFARCTION 35
722 BRADYPHRENIA 35
723 CARPAL TUNNEL SYNDROME 35
724 FORMICATION 35
725 HOMICIDE 35
726 HYPOAESTHESIA ORAL 35
727 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 35
728 MOUTH SWELLING 35
729 SINUS TACHYCARDIA 35
730 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 35
731 TOXIC ENCEPHALOPATHY 35
732 ACTIVITIES OF DAILY LIVING IMPAIRED 34
733 ANHEDONIA 34
734 CAESAREAN SECTION 34
735 CATARACT 34
736 EYE SWELLING 34
737 HYPERTHERMIA 34
738 HYPOCALCAEMIA 34
739 HYPOPHAGIA 34
740 INCORRECT ROUTE OF DRUG ADMINISTRATION 34
741 JAUNDICE 34
742 MULTIPLE SCLEROSIS RELAPSE 34
743 MUSCLE ATROPHY 34
744 NEONATAL RESPIRATORY DISTRESS 34
745 ORAL PAIN 34
746 PELVIC PAIN 34
747 PSYCHOMOTOR SKILLS IMPAIRED 34
748 SPUTUM DISCOLOURED 34
749 TACHYPNOEA 34
750 TOOTH EXTRACTION 34
751 ACCIDENTAL DEATH 33
752 CHOKING 33
753 DEAFNESS NEUROSENSORY 33
754 DERMATITIS 33
755 HYPERGLYCAEMIA 33
756 INJECTION SITE DISCOLOURATION 33
757 KIDNEY INFECTION 33
758 MONOPLEGIA 33
759 PAIN IN JAW 33
760 PRODUCT COMPLAINT 33
761 RHESUS INCOMPATIBILITY 33
762 SPINAL OSTEOARTHRITIS 33
763 SPINAL STENOSIS 33
764 ANKYLOSING SPONDYLITIS 32
765 BODY TEMPERATURE INCREASED 32
766 CLUMSINESS 32
767 ECONOMIC PROBLEM 32
768 FAECES DISCOLOURED 32
769 FOOT DEFORMITY 32
770 HYPERCAPNIA 32
771 IMPRISONMENT 32
772 INJECTION SITE NODULE 32
773 MATERNAL DRUGS AFFECTING FOETUS 32
774 MELAENA 32
775 OSTEOPENIA 32
776 RASH MACULAR 32
777 RESPIRATORY RATE DECREASED 32
778 TARDIVE DYSKINESIA 32
779 TRANSIENT ISCHAEMIC ATTACK 32
780 UROSEPSIS 32
781 VISCERAL CONGESTION 32
782 ABNORMAL LOSS OF WEIGHT 31
783 DRUG TOLERANCE DECREASED 31
784 FOETAL DISTRESS SYNDROME 31
785 FUNGAL INFECTION 31
786 GASTRITIS 31
787 HAEMATOMA 31
788 LOSS OF LIBIDO 31
789 PAIN OF SKIN 31
790 POLYNEUROPATHY 31
791 SPINAL FUSION SURGERY 31
792 THERAPEUTIC RESPONSE INCREASED 31
793 THROAT IRRITATION 31
794 ACNE 30
795 ANKLE FRACTURE 30
796 BLOOD PRESSURE DIASTOLIC DECREASED 30
797 CARDIOMYOPATHY 30
798 COLITIS 30
799 DIZZINESS POSTURAL 30
800 FACIAL PAIN 30
801 FOETAL DEATH 30
802 INTERNATIONAL NORMALISED RATIO INCREASED 30
803 METASTASES TO BONE 30
804 OVERWEIGHT 30
805 SCREAMING 30
806 SOCIAL AVOIDANT BEHAVIOUR 30
807 ABSCESS 29
808 ALCOHOLISM 29
809 APPLICATION SITE PUSTULES 29
810 COMMUNICATION DISORDER 29
811 FAECALOMA 29
812 GUN SHOT WOUND 29
813 HEART RATE ABNORMAL 29
814 HYPERTONIA 29
815 INJECTION SITE DISCOMFORT 29
816 PARAESTHESIA ORAL 29
817 PRODUCT COMMUNICATION ISSUE 29
818 PRODUCT PACKAGING DIFFICULT TO OPEN 29
819 SCAB 29
820 SKIN ABRASION 29
821 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 29
822 ALCOHOL POISONING 28
823 ANXIETY DISORDER 28
824 APPLICATION SITE INFECTION 28
825 ATAXIA 28
826 BLOOD PRESSURE DIASTOLIC ABNORMAL 28
827 EXPULSION OF MEDICATION 28
828 FAECES SOFT 28
829 FEBRILE NEUTROPENIA 28
830 GENERAL SYMPTOM 28
831 HYPOACUSIS 28
832 HYPOTONIA 28
833 INJECTION SITE URTICARIA 28
834 NEURODEGENERATIVE DISORDER 28
835 PERIPHERAL COLDNESS 28
836 PHARYNGEAL OEDEMA 28
837 SALIVARY HYPERSECRETION 28
838 TENDERNESS 28
839 TOOTH ABSCESS 28
840 TRANSAMINASES INCREASED 28
841 APPLICATION SITE PARAESTHESIA 27
842 CYSTITIS 27
843 DIVERTICULITIS 27
844 HAEMORRHOIDS 27
845 LYMPHADENOPATHY 27
846 NEUROTOXICITY 27
847 PANIC REACTION 27
848 PARALYSIS 27
849 POTENTIATING DRUG INTERACTION 27
850 SINUS CONGESTION 27
851 SUBSTANCE DEPENDENCE 27
852 SWOLLEN JOINT COUNT 27
853 VICTIM OF CRIME 27
854 WEIGHT FLUCTUATION 27
855 BLOOD TESTOSTERONE DECREASED 26
856 BREECH PRESENTATION 26
857 CACHEXIA 26
858 FRACTURE 26
859 GASTROINTESTINAL MOTILITY DISORDER 26
860 GINGIVAL PAIN 26
861 HYPERVENTILATION 26
862 INCORRECT DRUG ADMINISTRATION DURATION 26
863 LEUKOCYTOSIS 26
864 MICROCEPHALY 26
865 SCRATCH 26
866 SEDATION COMPLICATION 26
867 SKIN INFECTION 26
868 ULCER 26
869 VAGINAL HAEMORRHAGE 26
870 ADRENAL INSUFFICIENCY 25
871 AGEUSIA 25
872 ANAPHYLACTIC SHOCK 25
873 BRUXISM 25
874 EYE HAEMORRHAGE 25
875 EYE INJURY 25
876 HUNGER 25
877 IMMUNODEFICIENCY 25
878 MICTURITION URGENCY 25
879 OSTEONECROSIS 25
880 PNEUMOTHORAX 25
881 POOR QUALITY PRODUCT ADMINISTERED 25
882 PRODUCT TEMPERATURE EXCURSION ISSUE 25
883 PULMONARY HYPERTENSION 25
884 SINUS DISORDER 25
885 SKIN LACERATION 25
886 SPONDYLITIS 25
887 AFFECT LABILITY 24
888 DECREASED INTEREST 24
889 FEELING OF DESPAIR 24
890 GAMMA-GLUTAMYLTRANSFERASE INCREASED 24
891 HEPATIC FIBROSIS 24
892 INCREASED APPETITE 24
893 ISCHAEMIC STROKE 24
894 MUSCULOSKELETAL DISCOMFORT 24
895 NEEDLE ISSUE 24
896 PRE-ECLAMPSIA 24
897 SUICIDAL BEHAVIOUR 24
898 TACHYPHRENIA 24
899 TRANSFUSION 24
900 WRIST FRACTURE 24
901 ARTERIOSCLEROSIS 23
902 ARTERIOSCLEROSIS CORONARY ARTERY 23
903 BLOOD GLUCOSE DECREASED 23
904 CENTRAL SLEEP APNOEA SYNDROME 23
905 CEREBRAL DISORDER 23
906 CONJUNCTIVAL HAEMORRHAGE 23
907 DEFAECATION DISORDER 23
908 ELECTRIC SHOCK SENSATION 23
909 EXPIRED PRODUCT ADMINISTERED 23
910 FULL BLOOD COUNT ABNORMAL 23
911 HAEMOPTYSIS 23
912 INJECTION SITE OEDEMA 23
913 INSURANCE ISSUE 23
914 NECK INJURY 23
915 NEOPLASM PROGRESSION 23
916 PANIC DISORDER 23
917 PARKINSON^S DISEASE 23
918 PLACENTAL HYPERTROPHY 23
919 PRODUCT PREPARATION ERROR 23
920 RENAL INJURY 23
921 RESPIRATORY ACIDOSIS 23
922 SENSITIVE SKIN 23
923 SUSPECTED SUICIDE 23
924 TEMPERATURE INTOLERANCE 23
925 TOOTH INFECTION 23
926 VICTIM OF SEXUAL ABUSE 23
927 ACUTE HEPATIC FAILURE 22
928 BLOOD PRESSURE SYSTOLIC DECREASED 22
929 CENTRAL PAIN SYNDROME 22
930 CHOLESTASIS 22
931 CLEFT PALATE 22
932 CRANIOCEREBRAL INJURY 22
933 DRUG EFFECT DELAYED 22
934 ECHOCARDIOGRAM ABNORMAL 22
935 EYE DISORDER 22
936 HEPATIC CYTOLYSIS 22
937 HOMICIDAL IDEATION 22
938 INJECTION SITE SCAR 22
939 LABELLED DRUG-DRUG INTERACTION ISSUE 22
940 LOSS OF EMPLOYMENT 22
941 MUSCLE TIGHTNESS 22
942 NEUTROPHIL COUNT DECREASED 22
943 ORAL CANDIDIASIS 22
944 SKIN NECROSIS 22
945 SUSPECTED OFF LABEL USE 22
946 UPPER LIMB FRACTURE 22
947 VIRAL INFECTION 22
948 BLOOD ALBUMIN DECREASED 21
949 BLOOD POTASSIUM INCREASED 21
950 CLUSTER HEADACHE 21
951 COMA SCALE ABNORMAL 21
952 CORONARY ARTERY DISEASE 21
953 DECREASED ACTIVITY 21
954 DROOLING 21
955 DRUG ABUSER 21
956 ELECTROLYTE IMBALANCE 21
957 END STAGE RENAL DISEASE 21
958 ENERGY INCREASED 21
959 EYE PRURITUS 21
960 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 21
961 GALLBLADDER DISORDER 21
962 HALLUCINATIONS, MIXED 21
963 HYDRONEPHROSIS 21
964 IMMUNOSUPPRESSION 21
965 INITIAL INSOMNIA 21
966 JUDGEMENT IMPAIRED 21
967 METASTASES TO LUNG 21
968 MULTIPLE FRACTURES 21
969 TONGUE ULCERATION 21
970 TUBULOINTERSTITIAL NEPHRITIS 21
971 URINARY HESITATION 21
972 ABASIA 20
973 ATRIAL SEPTAL DEFECT 20
974 BLOOD ALKALINE PHOSPHATASE INCREASED 20
975 BLOOD DISORDER 20
976 BLOOD POTASSIUM DECREASED 20
977 BONE DENSITY ABNORMAL 20
978 CARDIOGENIC SHOCK 20
979 COAGULOPATHY 20
980 DISEASE RECURRENCE 20
981 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 20
982 GINGIVITIS 20
983 GLOMERULAR FILTRATION RATE DECREASED 20
984 INJECTION SITE HYPERSENSITIVITY 20
985 MUSCULOSKELETAL CHEST PAIN 20
986 MUSCULOSKELETAL DISORDER 20
987 NEONATAL RESPIRATORY DISTRESS SYNDROME 20
988 NEPHROPATHY 20
989 PHOTOSENSITIVITY REACTION 20
990 PLASMA CELL MYELOMA 20
991 RESPIRATION ABNORMAL 20
992 SLOW SPEECH 20
993 SLUGGISHNESS 20
994 VENOUS THROMBOSIS 20
995 VENTRICULAR TACHYCARDIA 20
996 ABDOMINAL PAIN LOWER 19
997 APHONIA 19
998 ASPARTATE AMINOTRANSFERASE INCREASED 19
999 BLOOD PRESSURE ABNORMAL 19